Related by context. All words. (Click for frequent words.) 69 Logistic regression analysis 69 Multivariate analysis 69 Logistic regression 68 multivariable logistic regression 67 logistic regression analyzes 67 multivariate analyzes 67 Multiple logistic regression 66 multiple logistic regression 65 Univariate analysis 64 Multivariable logistic regression 64 Subgroup analyzes 64 Multivariate logistic regression 64 conditional logistic regression 63 logistic regression analysis 63 Univariate 63 multivariate logistic regression 63 multivariable analysis 63 logistic regression models 63 Logistic regression analyzes 62 Multivariate analyzes 62 univariate 62 multivariate regression analysis 61 Meta analyzes 61 bivariate analysis 61 Multiple linear regression 60 intraobserver 60 multiple linear regression 60 metabolite concentrations 60 univariate analysis 60 retrospective cohort 60 posttest 60 Liver biopsies 60 logistic regression model 60 Kaplan Meier analysis 59 phylogenetic analyzes 59 subscales 59 logistic regressions 59 meta regression 59 retrospective observational study 59 univariate analyzes 59 immunohistochemical analysis 59 logistic regression 59 multivariable analyzes 59 covariate 59 anthropometric measurements 59 adenotonsillectomy 59 HOMA IR 59 Cronbach alpha 59 Subgroup analysis 59 convergent validity 59 randomized controlled trials RCTs 58 COMT genotype 58 interobserver 58 linear regression analyzes 58 multivariate Cox 58 semistructured interviews 58 interobserver reliability 58 Linear regression 58 Pearson correlation coefficients 58 immunohistochemical 58 PROactive study 58 Pearson correlation coefficient 58 chest radiographs 58 serum lipid levels 58 HRQL 58 ImmuKnow assay 58 bivariate 58 binary logistic regression 58 generalized estimating 57 ANCOVA 57 APOE genotype 57 odds ratios ORs 57 semiquantitative 57 EQ 5D 57 Sensitivity analyzes 57 posttreatment 57 Oncotype DX Recurrence Score 57 Cardiorespiratory fitness 57 interrater reliability 57 hsCRP levels 57 HRQoL 57 intact parathyroid hormone 57 Female Sexual Function 57 covariates 57 urodynamic 56 Child Behavior Checklist 56 actigraphy 56 multivariate regression 56 ANOVA 56 confidence intervals CIs 56 RRM1 56 FeNO 56 observational cohort study 56 predictive validity 56 clinically meaningful improvement 56 CIN2 + 56 sociodemographic variables 56 ROC curves 56 dose proportionality 56 glycated hemoglobin HbA1c 56 Montgomery Åsberg Depression 56 Immunohistochemical analysis 56 stepwise logistic regression 56 core needle biopsies 56 CORE OM 56 transthoracic echocardiography 56 genotypic resistance 56 Observational studies 56 Cystatin C 56 Pharmacokinetic parameters 56 multivariable Cox 56 Likert scale 56 Plain radiographs 56 EuroSCORE 56 oncologic outcomes 56 duplex ultrasonography 56 ConclusionThis 56 F FDG PET 56 EEG recordings 56 CIMZIA ™ 56 retest reliability 56 metabolic parameters 56 multivariate analysis 56 pharmacodynamic properties 56 histopathologic 56 Descriptive statistics 56 callous unemotional traits 56 #F FDG PET 56 calculated creatinine clearance 56 premorbid 56 Echocardiographic 56 observable behaviors 56 Poisson regression 56 differentially expressed genes 55 FDG-PET/CT 55 neuroimaging studies 55 spirometric 55 SNP rs# [002] 55 psychometric properties 55 Microscopic examination 55 DLQI 55 colorectal neoplasia 55 cobas HPV Test 55 Regression analysis 55 electrophysiologic 55 prostate cancer CaP 55 transvaginal sonography 55 neuropsychological assessment 55 transient elastography 55 HORIZONS AMI trial 55 subscale scores 55 intima media thickness 55 sociodemographic characteristics 55 regression analyzes 55 MMSE score 55 Primary endpoints 55 carotid IMT 55 transcriptional profiling 55 retrospective cohort study 55 PCWP 55 viral kinetics 55 prospective longitudinal 55 PIRLS 55 serum leptin 55 AVERROES 55 microalbumin 55 APTIMA HPV 55 Brief Psychiatric 55 NHANES III 55 estimated GFR 55 exploratory endpoints 55 DAS# CRP 55 erection hardness 55 genomewide association study 55 interrater 55 scintigraphic 55 PCI ExTRACT TIMI 55 plasma pharmacokinetics 55 subgroup analyzes 55 serum estradiol 55 immunohistochemical staining 55 Bonferroni correction 55 subanalysis 55 intraclass correlation coefficients 55 Kaplan Meier survival 55 ELISpot 55 bivariate analyzes 55 CIMZIA TM certolizumab pegol 55 virologic responses 55 Secondary efficacy endpoints 55 Recurrence Score 55 vitro experiments 55 BMI waist circumference 55 YMRS 55 BUSM researchers 55 statistically significant efficacy 55 FENO 54 linear regression analysis 54 hemostatic efficacy 54 psychopathological symptoms 54 clinicopathological 54 QTc prolongation 54 colonoscopic 54 pathologic examination 54 microarray gene expression 54 Skin sterol 54 nodal metastasis 54 point Likert scale 54 RE LY trial 54 Statistical analyzes 54 linear regressions 54 exhaled nitric oxide 54 dietary questionnaires 54 sleeve lobectomy 54 Platelet counts 54 fasting serum 54 pharmacokinetics PK 54 prospectively stratified 54 virological response 54 HRQOL 54 STRIDE PD 54 sociodemographic 54 pCR 54 prospective observational 54 RE LY ® 54 pharmacokinetic pharmacodynamic 54 Interrater reliability 54 Screening Trial 54 pharmacoeconomic analysis 54 phylogenetic analysis 54 serum concentrations 54 antioxidant supplementation 54 basal bolus regimen 54 mg BID dose 54 overnight polysomnography 54 psychiatric comorbidities 54 definite stent thrombosis 54 MDRD 54 HRCT 54 sociodemographic factors 54 HER2 overexpression 54 histopathological 54 airway responsiveness 54 Framingham Offspring 54 oral glucose tolerance 54 tumor histology 54 pharmacodynamic parameters 54 Coronary angiography 54 Epidemiologic studies 54 prospective observational studies 54 coronary artery calcification 54 nodal metastases 54 explanatory variables 54 pharmacokinetic characteristics 54 BMI z 54 eNO 54 postintervention 53 sustained virological response 53 subclinical atherosclerosis 53 Preoperatively 53 seropositivity 53 glomerular filtration 53 Functional magnetic resonance 53 seroprotection 53 fasting insulin 53 Kruskal Wallis test 53 PSA nadir 53 pharmacodynamic markers 53 T1 weighted images 53 CHADS2 53 Histological analysis 53 metaanalysis 53 GRAVITAS trial 53 EGFR mutation status 53 histologic findings 53 chi squared 53 myocardial viability 53 plain radiographs 53 genetic loci 53 undetectable HBV DNA 53 neuropsychological assessments 53 albumin excretion rate 53 NNRTI resistance 53 proband 53 SYNTAX trial 53 sonographic findings 53 Kaplan Meier method 53 OGTT 53 retrospectively analyzed 53 INTERHEART study 53 clinicopathologic 53 liver biopsies 53 statistically significant correlation 53 stratifying patients 53 Histologic 53 UGT#A# * 53 Negative Symptoms 53 genotype phenotype 53 Lumbar spine 53 atherogenic dyslipidemia 53 Masimo PVI 53 fetuin 53 Kaplan Meier curves 53 Intermountain Risk Score 53 prospective multicentre 53 ADAS Cog 53 extracolonic findings 53 anti JCV antibodies 53 FDG PET imaging 53 clinico pathological 53 antidepressant efficacy 53 biochemical recurrence 53 serum PTH 53 prospectively defined 53 Cytogenetic 53 methacholine challenge 53 sex hormones estradiol 53 transthoracic 53 DNA methylation markers 53 UKPDS 53 angiographically 53 CANCIDAS 53 Zevalin consolidation 53 NAMCS 53 estimated glomerular filtration 53 PIB PET 53 cerebral microbleeds 53 CHAMPION PCI 53 hsCRP 53 SpCO 53 variance ANOVA 53 nomogram 53 prospective multicenter study 53 Flow cytometry 53 PLCO trial 53 ADCS ADL 53 etiologic 53 pelvic ultrasound 53 desvenlafaxine succinate 53 EquiTrend ® 53 Kids Inpatient Database 53 meta analytic 53 AST ALT 53 genomewide 53 poor metabolizers 53 substudy 53 nonfasting triglyceride levels 53 Reynolds Risk Score 53 interobserver agreement 53 RECIST Response Evaluation Criteria 53 urine cytology 53 T SPOT.TB test 53 Baseline characteristics 53 urodynamic studies 53 cytologic 53 florbetaben 53 sensitivity specificity 53 DSM IV diagnoses 53 longitudinal cohort 53 Logistic regression models 53 Screening Trial DMIST 53 CARDIA 53 histopathological examination 53 SLNB 53 familial aggregation 53 CALGB 53 BODE index 53 neurocognitive function 53 KIF6 carriers 53 angiographic outcomes 53 sonographic examinations 53 secretory phospholipase A2 sPLA2 52 anthropometric measures 52 lymphocyte count 52 serum vitamin D 52 immunochemical 52 Principled Technologies 52 inhibin B 52 MBCT 52 MTT assay 52 histopathologic findings 52 DMIST 52 relapsed MM 52 SEER registry 52 EPDS 52 troponin T 52 Incontinence Impact Questionnaire 52 eC SSRS 52 Cochrane Systematic Review 52 skin sterol 52 hepatic lesions 52 dose Iluvien 52 inflammatory biomarkers 52 adiponectin concentrations 52 radiographic outcomes 52 KRAS status 52 fructosamine 52 Renal Cell Carcinoma RCC 52 EBUS FNA 52 Mantel Haenszel 52 statistically significant correlations 52 preoperative PSA 52 tHcy 52 eTag assays 52 mammographic density 52 covariance ANCOVA 52 NIHSS 52 pharmacokinetic PK profile 52 VerifyNow P#Y# 52 WOMAC pain 52 Coronary calcium 52 VADT 52 Histopathological 52 MetS 52 neurosensory 52 #OHD levels 52 Cervista HPV 52 fasting plasma 52 FDG PET 52 Visual acuity 52 Cochrane reviewers 52 psychodynamic therapy 52 tipranavir r 52 Wechsler Adult 52 p = .# [002] 52 psychiatric outpatients 52 Neuropsychiatric Inventory NPI 52 pulp metallic 52 HbA1C 52 pharmacokinetic equivalence 52 transesophageal echocardiography 52 psychosocial variables 52 internalizing behaviors 52 EDEMA3 trial 52 PD2i ® 52 telomere lengths 52 echocardiographic parameters 52 coronary calcification 52 Pharmacodynamic 52 IIEF 52 echocardiographic 52 DCE MRI 52 allele frequencies 52 prognostic factors 52 urine NGAL 52 nonparametric 52 KRAS mutations 52 Swedish Mammography Cohort 52 glycosylated hemoglobin HbA1c 52 gamma spectrometry 52 symptomatic VTE 52 transcriptomic 52 Liver biopsy 52 pharmacodynamic effects 52 Longitudinal studies 52 cystatin C 52 fMRI scans 52 Carotid Revascularization Endarterectomy vs. 52 glycated hemoglobin 52 Scale Cognitive Subscale 52 Likert 52 EMPHASIS HF trial 52 quantitative coronary angiography 52 radiation dosimetry 52 HDRS 52 CPAP adherence 52 colonography 52 FDG PET CT 52 electroencephalograms 52 XRF analyzes 52 statistically nonsignificant 52 FDG PET scans 52 glycated hemoglobin levels 52 depressive symptomatology 52 genotypic 52 monoinfected patients 52 CYP#D# genotype 52 clinical pharmacology studies 52 postdischarge 52 cotinine levels 52 serologic 52 RCTs 52 HER2 expression 52 Capacity FVC 52 radical cystectomy 52 gene polymorphisms 52 dietary intakes 52 Study AREDS 52 Histopathologic 52 APOE e4 52 prospectively randomized 52 urine albumin 52 nonexposed 52 GAMMAGARD 52 transabdominal 52 prognostic markers 52 SpHb monitoring 52 serum clusterin levels 52 SpHb 52 riociguat 52 dosage regimens 52 histopathologic diagnosis 52 autistic traits 52 nonfasting 52 NCDB 52 prognostic indicators 52 Randomized clinical trials 52 visceral adiposity 52 preoperatively 52 CCyR 52 cytoreductive nephrectomy 52 intraclass correlation coefficient 52 precaution Wiehle 52 TKAs 52 pharmacokinetic studies 52 lymphovascular invasion 52 coronary stenosis 52 Urogenital Distress Inventory 52 depressive symptom 52 Microarray analysis 52 psychiatric morbidity 52 Digital Mammographic Imaging 52 serum albumin 52 ELISPOT 52 biostatistical analysis 52 serum phosphorous 52 phase IIIb 52 arterial thickening 52 SF #v# 52 Tumor Response 52 NASA COBE satellite 52 core needle biopsy 52 Wilcoxon rank sum 51 bone scintigraphy 51 antibody titer 51 baseline HbA1c 51 Genotypic 51 pharmacodynamic endpoints 51 adenoma recurrence 51 preintervention 51 serum ferritin 51 preclinically 51 IL#B 51 serum cortisol 51 susceptibility loci 51 multicenter randomized clinical 51 intraoperative ultrasound 51 QoL 51 MR spectroscopy 51 HIV tropism 51 Angiographic 51 multicenter trials 51 EGFR expression 51 endoscopic remission 51 Cystic Fibrosis Questionnaire Revised 51 careHPV 51 specific antigen PSA 51 S. maltophilia 51 PLCO 51 nonrandomized studies 51 CONCERTA ® 51 recursive partitioning 51 Lp PLA 2 51 salivary cortisol 51 tertiles 51 Fibromyalgia Impact Questionnaire 51 rs# [002] 51 advanced neoplasia 51 CC genotype 51 correlational 51 Symptom severity 51 facial attractiveness 51 episodic migraine sufferers 51 analgesic efficacy 51 ADAS cog 51 trials RCTs 51 polysomnogram 51 Stenting Trial CREST 51 euthymic patients 51 KRAS mutation status 51 neuropathologic 51 Epworth Sleepiness Scale 51 multiplex PCR 51 hematological parameters 51 pharmacokinetic parameters 51 -#.# ± [002] 51 inhaled corticosteroid therapy 51 induced sputum 51 RQ PCR 51 MADIT CRT trial 51 quantitative PCR 51 PON1 activity 51 subtests 51 pharmacodynamic PD 51 RNA seq 51 PANSS 51 differential gene expression 51 Treatment Outcome 51 waist circumference WC 51 longitudinal cohort study 51 reboxetine 51 unpaired t 51 BMI percentile 51 multivariable regression 51 preclinical efficacy 51 NHAMCS 51 liver transplant recipients 51 STEP BD 51 transcranial Doppler 51 transcranial Doppler ultrasound 51 proportional hazards 51 ExTRACT TIMI 51 digital rectal examination 51 FOLPI 51 rs# [004] 51 cardio respiratory fitness 51 dichotomous variables 51 randomized multicenter trial 51 caustic fusion diamond 51 Sociodemographic 51 Scale PANSS 51 Cervista HPV HR 51 Related Conditions NESARC 51 ERSPC 51 Index CDAI 51 transesophageal echocardiography TEE 51 SUVmax 51 Solid Tumours 51 anti Mullerian hormone 51 ARB telmisartan 51 PHQ 9 51 solifenacin 51 virologic response 51 variant rs# 51 cognitive domains 51 obstructive coronary artery 51 patient subpopulations 51 KRAS mutation 51 glucose insulin 51 eosinophil count 51 microarray analysis 51 ER CHOP 51 BRCA2 mutation carriers 51 MMSE scores 51 HBeAg 51 Oncotype DX ® 51 tertile 51 platelet reactivity 51 polysomnography PSG 51 PSQI 51 NIH CPSI 51 genetic polymorphisms 51 serum lipid 51 ultrasonographic 51 #q# deletion syndrome 51 coinfected patients 51 abdominal ultrasounds 51 HbA 1c levels 51 conventional coronary angiography 51 femoral neck BMD 51 SPEC benchmark 51 BPS IC 51 microalbumin test 51 LV dysfunction 51 atherothrombotic disease 51 hydroxyvitamin D levels 51 lipid parameters 51 prognostic significance 51 journal Ophthalmology 51 Global Impression CGI 51 prognostic variables 51 HbA 1c 51 d dimer 51 mg/m2 dose 51 attention-deficit/hyperactivity disorder ADHD 51 prospective cohort 51 Immunohistochemistry IHC 51 PD2i R 51 IVTA 51 DCCT 51 singleton pregnancies 51 Index FSFI 51 rs# [001] 51 Depressive symptoms 51 albumin excretion 51 GYTS 51 suicide attempters 51 CYP#C# genotype 51 SGRQ 51 trastuzumab emtansine T DM1 51 Electroencephalography 51 fluvastatin 51 mammographically 51 guaiac 51 HERmark 51 chlamydial infection 51 Montgomery Asberg Depression 51 2D 4D ratio 50 mITT population 50 EUS FNA 50 GABRA2 50 Millennium Cohort Study 50 deCODE BreastCancer TM 50 DNA methylation patterns 50 cystoscopic 50 Radiographs 50 summative assessments 50 androgen depletion 50 polysomnography 50 ELISA enzyme 50 CSF biomarkers 50 preoperative MRI 50 vivo assays 50 favorable pharmacokinetic profile 50 serum markers 50 LDL particle 50 BACcel ™ system 50 serological tests 50 guideline concordant 50 brachial artery flow 50 SYNTAX 50 RECIST criteria 50 nonobese 50 IMPROVE HF 50 cecal intubation 50 PITX2 50 clomipramine 50 microsatellite markers 50 serum HCV RNA 50 prospective observational cohort 50 morphometry 50 semistructured interview 50 clinicopathological features 50 Rating Scale BPRS 50 myocardial uptake 50 interindividual variability 50 liver histology 50 serum cotinine 50 endophenotypes 50 mRNA expression 50 longitudinal observational study 50 EDSS score 50 Wisconsin Sleep Cohort 50 OBPM 50 Geriatric Depression 50 coronary artery calcium 50 Likert type 50 immunohistochemistry IHC 50 lipid profiles 50 MERIT ES 50 Netherlands Cohort Study 50 CHAMPION PLATFORM 50 alexithymia 50 Phylogenetic analyzes 50 subscore 50 NESARC 50 hierarchical clustering 50 Post hoc 50 MHQP 50 electron beam computed tomography 50 Lp PLA2 50 Hamilton Anxiety Scale 50 DEXA scans 50 axial length 50 Methods Retrospective 50 endometrial thickness 50 IGRAs 50 QRISK 50 viral kinetic 50 SCK difficulty 50 MTWA testing 50 HDL cholesterol triglycerides 50 erythrocyte sedimentation rate 50 SNP rs# [001] 50 CT perfusion 50 nondiabetic patients 50 SerDes transceivers 50 CNS LS 50 microRNA expression 50 trastuzumab Herceptin ® 50 HAM D 50 histologic examination 50 perinatal outcomes 50 nutrient intakes 50 CSAMT MT 50 metabolomic 50 dyslipidaemia 50 promoter methylation 50 Vasotrac 50 apolipoprotein B 50 rFSH 50 D Dimer 50 noninferiority 50 Pharmacokinetic studies 50 parasitological 50 eculizumab therapy 50 body habitus 50 doxorubicin docetaxel 50 Glasgow Coma Scale 50 Quantitative RT PCR 50 Randomized trials 50 predictor variables 50 IntroductionThe 50 perfusion abnormalities 50 squamous intraepithelial lesions 50 steroid dexamethasone 50 perioperative morbidity 50 CARE HF 50 APTIVUS r 50 HbA 1C 50 serum uric acid 50 sentinel surveillance 50 serum CRP 50 cortex thickness 50 neurophysiologic 50 BHEM surveys 50 mg kg dose 50 tipranavir ritonavir 50 downhole gamma logging 50 N telopeptide 50 Corus CAD 50 atherosclerotic progression 50 electrospray ionisation 50 MADRS score 50 Thrombolysis 50 Cotinine 50 Ovarian PLCO Cancer 50 hemoglobin A1C 50 darbepoetin alpha 50 crizotinib PF # 50 Pharmacokinetic PK 50 cTnT levels 50 VerifyNow P#Y# Test 50 cardiac perfusion 50 Oncotype DX TM 50 cerebral angiography 50 flurpiridaz F 50 epidemiologic studies 50 pexelizumab trials 50 phase IIb study 50 NSQIP 50 CaPre TM 50 Non inferiority 50 Pharmacokinetic analysis 50 STAT3 signaling 50 LDL HDL 50 RAPAFLO R 50 intradermal injections 50 heterozygotes 50 DAS# scores 50 morphometric vertebral fractures 50 proteomic analyzes 50 metabolomic profiling 50 pharmacokinetic interaction 50 HbA1C levels 50 cortical activation 50 correlation coefficients 50 T2D 50 serological 50 Efficacy endpoints 50 radiographic examinations 50 ACS NSQIP 50 microRNA profiling 50 glycosylated hemoglobin levels 50 variograms 50 subjective sleepiness 50 Change PGIC 50 NCT# ClinicalTrials.gov 50 OPCAB 50 LUTS 50 haplotype map 50 urolithiasis 50 Edinburgh Postnatal Depression 50 nomograms 50 genetic variants associated 50 oral anticoagulation 50 HBeAg negative patients 50 APACHE II 50 NLSY 50 silent myocardial ischemia 50 chest radiograph 50 serum urate levels 50 placebo controlled clinical trials 50 Phase IIIb study 50 secondary efficacy endpoints 50 periprocedural 50 MSLT 50 HBeAg seroconversion 50 multivariate adjustment 50 genomic biomarkers 50 Hp2 2 50 HIV seroconversion 50 thickness CIMT 50 polysomnographic 50 paricalcitol 50 Solorel TM 50 Hb A1C 50 rEEG 50 serum selenium 50 ICD implantations 50 neural correlates 50 Difficulties Questionnaire 50 adenoma detection 50 extramedullary 50 pharmacokinetic PK 50 coronary CTA 50 COR Analyzer 50 Crohn Disease Activity 49 immunochemical fecal occult 49 triglyceride concentrations 49 methylation markers 49 adjuvant tamoxifen 49 Quality Indicators 49 PCA3 49 nonpregnant women 49 multivariable 49 serum GGT 49 ToGA 49 Insulin sensitivity 49 dyads 49 multicentre prospective 49 perfusion MRI 49 airway hyperresponsiveness 49 Randomised controlled trials 49 Erectile function 49 BEXXAR Therapeutic Regimen 49 Stroop task 49 mineralogical studies 49 Mechanistic studies 49 Health Assessment Questionnaire 49 cardiac autonomic 49 postoperative radiographs 49 SYNTAX Score 49 creatinine ratio 49 Viral load 49 State Exam MMSE 49 serum testosterone 49 hemodynamic parameters 49 remission CR 49 seroconverted 49 waist circumference measurements 49 cytological 49 GPRD 49 formal pharmacokinetic PK 49 petrographic 49 chemometric 49 residual platelet reactivity 49 familial clustering 49 internalizing disorders 49 Survey MEPS 49 bepotastine besilate nasal spray 49 hemoglobin A1c levels 49 safety tolerability pharmacokinetic 49 NSDUH 49 functional MRI fMRI 49 orofacial clefts 49 Main Outcome Measure 49 Complications Trial 49 Visual Analog Scale 49 beta carotene supplementation 49 hemodynamic variables 49 UPDRS motor 49 randomized blinded 49 galiximab 49 facial symmetry 49 Endo PAT 49 postprandial hyperglycemia 49 circulating endothelial cells 49 DEXA scan 49 lignan intake 49 NLX P# 49 sonographic examination 49 SLN biopsy 49 postoperative chemotherapy 49 dietary calcium intake 49 methacholine 49 oral diclofenac 49 phthalate metabolites 49 borehole electromagnetic 49 ECASS 49 clopidogrel pretreatment 49 adjuvant systemic 49 TAXUS ARRIVE 49 MDQ 49 Visual Analog 49 inter rater reliability 49 comorbid diagnoses 49 Bonferroni 49 sentinel lymph node biopsy 49 audiometric 49 PSADT 49 System IPSS 49 Employee Engagement Survey 49 syndromic 49 HCV RESPOND 2 49 multicenter randomized controlled 49 highest tertile 49 clinically localized prostate 49 differentiate squamous